Evaluation of cell death after thermal ablation in patients with bone tumors
Introduction . Bone tumors are heterogeneous group of skeletal neoplasms characterized by frequent recurrences, aggressive clinical course and low survival rates. The development of new treatment methods continues to pose pressing challenges. Radical intraoperative thermal ablation (RIT) using high-temperature exposure is emerging as a new and promising strategy for organ-preserving treatment. This study focuses on the effect of thermal ablation (TA) on tumors. Objective of the Study to assess the impact of TA (using the RIT method) on the viability of tumor cells. Material and Methods . The study included 8 patients with bone tumors. Tumors underwent TA at a temperature of 60 °C for 30 minutes ex vivo. Apoptosis was studied in tumor tissue samples before and after TA. Apoptosis was assessed using two methods: flow cytometry and the TUNEL assay. Results. The TA procedure developed by our scientific group represents a promising organ-preserving approach for treating malignant bone tumors. A temperature regime of 60 °C for 30 minutes was effective in initiating tumor cells death. This was confirmed by two independent methods – flow cytometry and TUNEL assay – which demonstrated a significant increase in the number of apoptotic cells immediately following the procedure and a notable rise in the number of cells exhibiting signs of late apoptosis one hour post thermal ablation. Therefore, the collected data confirm a pronounced antitumor effect immediately after implementing RIT. Conclusion. The findings confirm that RIT is a viable organ-preserving method for treating bone tumors, meriting further investigation to expand its application in clinical practice.
Authors
- R. V. Zeltchan (ORCID: https://orcid.org/0000-0002-4568-1781)
- Л. А. Таширева (ORCID: https://orcid.org/0000-0003-2061-8417)
- D. M. Loos (ORCID: https://orcid.org/0000-0002-4098-6076)
- Anna Yu. Kalinchuk (ORCID: https://orcid.org/0000-0003-2106-3513)
- С. А. Табакаев (ORCID: https://orcid.org/0000-0002-1427-0162)
- Denis Pakhmurin (ORCID: https://orcid.org/0000-0002-5191-6938)
- V. V. Pakhmurina
- I. I. Anisenya (ORCID: https://orcid.org/0000-0003-3882-4665)
- P. K. Sitnikov (ORCID: https://orcid.org/0000-0003-0674-2067)
- Evgeniya S. Grigoryeva (ORCID: https://orcid.org/0000-0003-4737-8951)
- S. Yu. Matyushkov
Institutions
- Tomsk State University of Control Systems and Radio-Electronics (RU)
- Russian Academy of Sciences (RU)
- Siberian State Medical University (RU)
- Tomsk National Research Medical Center (RU)
Publication Details
- Journal
- Siberian Journal of Oncology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.21294/1814-4861-2025-24-3-38-49
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Higher Education of the Russian Federation